Using a Dox-inducible system, we examined the impact of restoring EHD3 expression to two glioma cell lines that express very low levels of EHD3, i.e. the U251 and U87MG cells, on the expression of EGFR. This evidence concerns the gene EGFR and central nervous system cancer.